Evidence map›Paper›PMID 33204007›Full record

ReviewInternational journal of impotence research2021

Prevalence of post-prostatectomy erectile dysfunction and a review of the recommended therapeutic modalities.

Thiago Fernandes Negris Lima, Joshua Bitran, Fabio Stefano Frech, Ranjith Ramasamy

Abstract readReview
PubMed Publisher
In one paragraph

Review in International journal of impotence research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Focal ablation therapy presents promising results for selectively localized prostate cancer patients.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2023
    Article
  16. The direct prognosis comparison ofEuropean journal of medical research · 2023
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Thiago Fernandes Negris LimaDepartment of Urology, University of Miami Miller School of Medicine, Miami, FL, United States of America. thiagofernandesnl@gmail.com.ORCID http://orcid.org/0000-0002-7410-7025
Joshua BitranDepartment of Urology, University of Miami Miller School of Medicine, Miami, FL, United States of America.
Fabio Stefano FrechDepartment of Urology, University of Miami Miller School of Medicine, Miami, FL, United States of America.ORCID http://orcid.org/0000-0002-0689-6464
Ranjith RamasamyDepartment of Urology, University of Miami Miller School of Medicine, Miami, FL, United States of America.
University of Miami · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radical prostatectomy (RP) represents one of the most commonly used first-line treatment modalities in men with localized prostate cancer. One of the most feared post-surgical complications is erectile dysfunction (ED), usually caused by direct damage to the cavernous nerves or due to neuropraxia. Penile rehabilitation is an emerging concept that was proposed to stimulate and accelerate recovery of erectile function after RP. The goal is to improve blood flow to the penis, increasing cavernous oxygenation and avoiding fibrosis. The most common used modalities include oral phosphodiesterase type 5 inhibitors (PDE5-I), vacuum erection devices (VEDs), intracorporeal injection (ICI) therapy, medicated urethral system for erections (MUSE), and a combination of these treatments. For those patients with severe ED, ED refractory to medical therapy and/or seeking long term reliable results, the penile prosthesis implant remains an excellent alternative. We conducted a broad review of post-prostatectomy ED prevalence with different techniques and the success rates of the different therapeutic approaches.

Indexed as

Erectile DysfunctionProstatic NeoplasmsHumansMalePenile ErectionPhosphodiesterase 5 InhibitorsPrevalenceProstatectomyPhosphodiesterase 5 Inhibitors

Identifiers

PMID33204007
OpenAlexW3106407290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.